Pricing Log in Create free account
Friday 6 November 2026 Export VCYT’s income statement to Excel — free account

Veracyte, Inc.

VCYT Healthcare Diagnostics & Research

Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.

Revenue
+15.1%
EPS
+62.5%
Free cash flow
−9.63%

Quarter to September 2026, against a year earlier

24.16 0.16 +0.67%
Market cap
$1.9B
P/E
15.2×
Fwd P/E
45.2×
Dividend yield
—
F-score
8/9
Altman Z
21.08
Beneish M
−2.66
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Veracyte, Inc. (VCYT) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Veracyte, Inc. (VCYT) trades at a EV/Sales of 2.5×. Over the past ten years it has ranged from 1.7× (March 2016) to 33.9× (February 2021); the current reading is higher than 4% of that period. That is below the Diagnostics & Research industry median of 5.2× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 5.6× (8.89%)
FY2024 6.2× 25.02%
FY2023 4.9× 1.03%
FY2022 4.9× (59.23%)
FY2021 11.9× (37.88%)
FY2020 19.2× 104.64%
FY2019 9.4× 109.32%
FY2018 4.5× 46.30%
FY2017 3.1× 2.98%
FY2016 3.0× (4.45%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 5.5× (26.12%)
Jun 2026 7.5× 91.17%
Mar 2026 3.9× (29.99%)
Dec 2025 5.6× 18.65%
43 more quarters

Against its own ten years

Low 1.7× High 33.9×
Ten-year median 5.0×
Current reading's percentile 4

EV/Sales against peers

Company EV/Sales
VCYT Veracyte, Inc. 2.5×
RDNT RadNet, Inc. compare 3.0×
NEO NeoGenomics, Inc. compare 3.3×
WGS GeneDx Holdings Corp. compare 4.2×
SHC Sotera Health Company compare 5.2×
CDNA CareDx, Inc. compare 7.6×
BLLN BillionToOne, Inc. compare 11.0×
ADPT Adaptive Biotechnologies Corporation compare 14.6×
GRAL GRAIL, Inc. compare 29.8×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on VCYT